Article
EGCG-Mediated Protection of Transthyretin Amyloidosis by Stabilizing Transthyretin Tetramers and Disrupting Transthyretin Aggregates.
International journal of molecular sciences - 15 Sept 2023
Zou Huizhen, Zhou Shuangyan
Abstract excerpt
Transthyretin amyloidosis (ATTR) is a progressive and systemic disease caused by the misfolding and amyloid aggregation of transthyretin (TTR). Stabilizing the TTR tetramers and disrupting the formed TTR aggregation are treated as a promising strategy for the treatment of ATTR. Previous studies have reported that epigallocatechin gallate (EGCG) can participate in the whole process of TTR aggregation to prevent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
